Note 6 - Notes Payable - Related Party (Details) (USD $)	9 Months Ended													2 Months Ended					11 Months Ended		6 Months Ended	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Oct. 31, 2013	Sep. 30, 2014 Investor [Member] Hayashibara Biochemical Laboratories, Inc. [Member]	Sep. 30, 2014 Majority Shareholder [Member] Loan One [Member] Hayashibara Biochemical Laboratories, Inc. [Member]	Sep. 30, 2014 Majority Shareholder [Member] Loan Two [Member] Hayashibara Biochemical Laboratories, Inc. [Member]	Sep. 30, 2014 Majority Shareholder [Member] Hayashibara Biochemical Laboratories, Inc. [Member]	Jan. 10, 2011 Director [Member] Principal [Member] Paul Tibbits [Member]	Jan. 10, 2011 Director [Member] Accrued Interest [Member] Paul Tibbits [Member]	Jan. 10, 2011 Director [Member] Paul Tibbits [Member]	May 19, 2012 Employee [Member] Pre Amendment [Member] Joseph Cummins [Member]	May 19, 2012 Employee [Member] As Amended [Member] Joseph Cummins [Member]	Dec. 01, 2012 Employee [Member] Joseph Cummins [Member]	Dec. 31, 2012 Employee [Member] Martin Cummins [Member]	Sep. 30, 2014 Employee [Member] Martin Cummins [Member]	Oct. 31, 2012 Employee [Member] Martin Cummins [Member]	Jul. 19, 2013 Chief Executive Officer [Member] On Material Unpaid Amount [Member] Unsecured Debt [Member] Stephen Chen [Member]	Jul. 19, 2013 Chief Executive Officer [Member] Unsecured Debt [Member] Stephen Chen [Member]	Sep. 30, 2014 Chief Executive Officer [Member] The Yang Group [Member] Stephen Chen [Member]	Jan. 15, 2014 Chief Executive Officer [Member] The Yang Group [Member] Stephen Chen [Member]	Jul. 19, 2013 Chief Executive Officer [Member] Stephen Chen [Member]	Dec. 31, 2012 Chief Executive Officer [Member] Stephen Chen [Member]	Sep. 30, 2014 Chief Executive Officer [Member] Stephen Chen [Member]	Jul. 25, 2013 Chief Executive Officer [Member] Stephen Chen [Member]
Note 6 - Notes Payable - Related Party (Details) [Line Items]
Number of Notes Payable				2
Debt Instrument, Face Amount					$ 1,000,000	$ 1,000,000				$ 200,000
Notes Payable, Related Parties							3,006,252.88	200,000	35,055.56									(976,793)
Debt Instrument, Interest Rate, Stated Percentage										10.00%							10.00%	23.00%
Employee Compensation, Annual Salary											175,000	60,000
Employee Compensation, Monthly Salary												5,000		5,000
Due to Employees											278,259			100,000	13,250	236,732
Due from Employees											10,448
Consultant Fee, Monthly													5,000
Gains (Losses) on Extinguishment of Debt														136,732
Payments to Employees														40,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period (in Shares)														879,000
Proceeds from Related Party Debt	261,892	573,835																	318,892		428,835	547,958
Line of Credit Facility, Maximum Borrowing Capacity	20,000																			285,000				300,000
Long-term Line of Credit	$ 18,376		$ 18,376																				$ 280,000